| Drug Type Small molecule drug | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism COX inhibitors(Cyclooxygenases inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePhase 1 | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 2 | United States  | - | |
| Muscular Dystrophy, Duchenne | Phase 1 | United States  | 30 Jan 2022 | |
| Myocardial Infarction | Phase 1 | United States  | 30 Jan 2022 | |
| Pulmonary Embolism | Phase 1 | United States  | 30 Jan 2022 | 





